Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S10 pseudogene 16 (RPS10P16)
- Target
- RPS10P16
- Molecular classification
- Other (Pseudogene; not a receptor, enzyme, transporter, channel, transcription factor, etc.)
01
Overview
Ribosomal protein S10 pseudogene 16 (RPS10P16) is a processed pseudogene found in the human genome, derived from the ribosomal protein S10 gene. It does not encode a functional protein, lacks clearly defined biological or disease roles, and does not act as a drug target or biomarker. While some pseudogenes may be transcribed, the majority—including RPS10P16—are considered nonfunctional genomic elements, reflecting evolutionary processes rather than current biological activity. Pseudogenes like RPS10P16 are abundant for ribosomal proteins due to evolutionary duplication and retrotransposition events. They are classified distinctly from functional “parent” genes. The functional ribosomal protein S10 gene (RPS10) is involved in ribosome composition and linked to Diamond-Blackfan anemia when mutated. RPS10P16 has no confirmed molecular function, disease implication, or druggability.
- Other names
- RPS10_4_945
02
Mechanism of action
None. Since it is a pseudogene and not a functional protein, there is no mechanism of action for drugs.
03
Biological functions
None as a direct pseudogene. Pseudogenes generally lack protein-coding capability but some may be transcriptionally active with unclear regulatory effects. No well-documented function for RPS10P16 specifically.
04
Disease associations
None documented for RPS10P16. It does not have a known role in disease; mutations in its parent gene, RPS10, are implicated in Diamond-Blackfan anemia, but not pseudogene 16.
05
Safety considerations
No direct safety concerns or therapeutic challenges are documented; pseudogenes are generally silent in terms of pharmacology.
Beyond the preview
Go deeper on Ribosomal protein S10 pseudogene 16 (RPS10P16).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein S10 pseudogene 16 (RPS10P16).